Skip to main
VERV
VERV logo

Verve Therapeutics (VERV) Market Capitalization Overview

Market Cap: $1.01B as of Jul 3, 2025

$1.01B
Past Month+$578.10M (135.25%)
As of Jul 3, 2025, Verve Therapeutics (VERV) has a market capitalization of $1.01B. Over the past 30 days, its market cap has increased by 135.25%, while in the last 12 months, it has increased by 110.58%.

Market capitalization represents the total value of Verve Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Verve Therapeutics (VERV) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Verve Therapeutics (VERV) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Verve Therapeutics (VERV) Market Cap History

DateMarket CapChange
Jul 1, 2025$1.01B+135.25%
Jun 2, 2025$427.45M-12.82%
May 1, 2025$490.29M+33.53%
Apr 1, 2025$367.18M-32.98%
Mar 3, 2025$547.88M-13.95%
Feb 3, 2025$636.68M+25.12%
Jan 2, 2025$508.83M-16.06%

Verve Therapeutics (VERV) End of Year Market Cap History

DateMarket CapChange
2025$1.01B+110.58%
2024$477.51M-56.39%
2023$1.10B-8.14%
2022$1.20B-32.88%
2021$1.78B

FAQs About Verve Therapeutics (VERV) Market Cap

As of Jul 3, 2025, the market capitalization of Verve Therapeutics (VERV) is $1.01B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Verve Therapeutics’s market capitalization has increased by 135.25%, changing from $427.45M to $1.01B as of Jul 3, 2025.

In the last 3 months, Verve Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Verve Therapeutics’s market capitalization decreased from $1.10B in January to $477.51M in December, reflecting a -56.39% change.

In the past five years, Verve Therapeutics (VERV) has had a compound annual growth rate (CAGR) of -27.99% in market capitalization. This means its market cap has shrunk at an average rate of -27.99% per year.

Verve Therapeutics (VERV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.